RecruitingNot ApplicableNCT04030507

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Screening Magnetic Resonance Imaging of the Brain in Patients With Metastatic Breast Cancer Managed With First/Second Line Chemotherapy or Inflammatory Breast Cancer Managed With Definitive Intent: A Prospective Study

Sponsor

Brigham and Women's Hospital

Enrollment

214 participants

Start Date

Jul 26, 2019

Study Type

INTERVENTIONAL

Conditions

Breast Cancer HER2-positive Breast Cancer

Summary

This research study is studying the usefulness of magnetic resonance imaging (MRI) to screen for brain metastases (spread of the breast cancer to the brain).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study uses brain MRI scans to check for hidden brain tumors in patients who have cancer that has spread from elsewhere in the body (metastatic cancer) and are about to start a new treatment. The goal is to see how often brain metastases are found that weren't previously detected. **You may be eligible if...** - You have a cancer that has spread to other parts of your body (metastatic cancer) - You are about to begin a new line of treatment - You have not had a brain MRI scan recently **You may NOT be eligible if...** - You have already had a recent brain MRI that is up to date - You have conditions that prevent you from having an MRI (e.g., certain metal implants) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMRI

MRI (which stands for magnetic resonance imaging) provide imaging of the brain which help look for brain metastases (spread of the breast cancer to the brain).

Locations(1)

Brigham and Women's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04030507

Related Trials

Genomic Services Research Program

NCT025959571 location

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

NCT052833304 locations

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

NCT070671381 location

Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)

NCT068852031 location

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

NCT06103864316 locations